CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(5.63%)
USD 0.01
(5.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -22.13 Million USD | 24.83% |
| 2022 | -17.78 Million USD | -14.54% |
| 2021 | -20.04 Million USD | -181.22% |
| 2020 | -5.52 Million USD | 73.44% |
| 2019 | -20.79 Million USD | -138.41% |
| 2018 | -8.72 Million USD | -2435.96% |
| 2017 | -343.88 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.82 Million USD | -77.01% |
| 2024 Q1 | -2.06 Million USD | 14.1% |
| 2023 Q4 | -1.42 Million USD | 59.21% |
| 2023 FY | - USD | 24.83% |
| 2023 Q3 | -3.5 Million USD | 4.08% |
| 2023 Q2 | -3.65 Million USD | 23.58% |
| 2023 Q1 | -4.78 Million USD | 14.64% |
| 2022 FY | - USD | -14.54% |
| 2022 Q4 | -5.6 Million USD | -38.42% |
| 2022 Q3 | -4.04 Million USD | 9.76% |
| 2022 Q2 | -4.48 Million USD | -22.72% |
| 2022 Q1 | -3.65 Million USD | 17.79% |
| 2021 Q2 | -3.98 Million USD | -36.44% |
| 2021 FY | - USD | -181.22% |
| 2021 Q1 | -2.91 Million USD | -22.46% |
| 2021 Q4 | -4.44 Million USD | -6.28% |
| 2021 Q3 | -4.18 Million USD | -4.99% |
| 2020 Q4 | -2.38 Million USD | -240.64% |
| 2020 FY | - USD | 73.44% |
| 2020 Q1 | -1.53 Million USD | 92.34% |
| 2020 Q2 | -904.19 Thousand USD | 41.08% |
| 2020 Q3 | -699.89 Thousand USD | 22.59% |
| 2019 Q1 | -273.14 Thousand USD | 90.91% |
| 2019 Q4 | -20.04 Million USD | -9953.4% |
| 2019 Q3 | -199.38 Thousand USD | 30.98% |
| 2019 FY | - USD | -138.41% |
| 2019 Q2 | -288.87 Thousand USD | -5.76% |
| 2018 Q1 | -137.87 Thousand USD | 0.0% |
| 2018 Q3 | -1.55 Million USD | -953.63% |
| 2018 Q2 | -147.97 Thousand USD | -7.33% |
| 2018 FY | - USD | -2435.96% |
| 2018 Q4 | -3 Million USD | -92.73% |
| 2017 Q3 | -140.84 Thousand USD | -179.26% |
| 2017 Q2 | -50.43 Thousand USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BIMI International Medical Inc. | -15.33 Million USD | -44.304% |
| China Jo-Jo Drugstores, Inc. | 1.22 Million USD | 1904.142% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 9.72 Million USD | 327.646% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 9.72 Million USD | 327.646% |
| Leafly Holdings, Inc. | -5.73 Million USD | -286.014% |
| Leafly Holdings, Inc. | -5.73 Million USD | -286.014% |
| LifeMD, Inc. | -8.21 Million USD | -169.459% |
| LifeMD, Inc. | -8.21 Million USD | -169.459% |
| TRxADE HEALTH, Inc. | -13.72 Million USD | -61.32% |
| PetMed Express, Inc. | -394 Thousand USD | -5517.773% |
| Walgreens Boots Alliance, Inc. | -11.27 Billion USD | 99.804% |